ES557404A0 - Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas. - Google Patents

Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas.

Info

Publication number
ES557404A0
ES557404A0 ES557404A ES557404A ES557404A0 ES 557404 A0 ES557404 A0 ES 557404A0 ES 557404 A ES557404 A ES 557404A ES 557404 A ES557404 A ES 557404A ES 557404 A0 ES557404 A0 ES 557404A0
Authority
ES
Spain
Prior art keywords
bacterial toxins
directed against
antibodies directed
against bacterial
dosage procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557404A
Other languages
English (en)
Other versions
ES8900068A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of ES557404A0 publication Critical patent/ES557404A0/es
Publication of ES8900068A1 publication Critical patent/ES8900068A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • G01N33/556—Fixed or stabilised red blood cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES557404A 1985-02-05 1987-02-16 Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas. Expired ES8900068A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8501579A FR2577048B1 (fr) 1985-02-05 1985-02-05 Reactif pour le dosage par hemagglutination des anticorps contre les toxines bacteriennes, procede de preparation et son application

Publications (2)

Publication Number Publication Date
ES557404A0 true ES557404A0 (es) 1988-11-16
ES8900068A1 ES8900068A1 (es) 1988-11-16

Family

ID=9315942

Family Applications (2)

Application Number Title Priority Date Filing Date
ES551659A Expired ES8800757A1 (es) 1985-02-05 1986-02-05 Procedimiento para preparar un reactivo para valorar por hemaglutinacion anticuerpos dirigidos contra toxinas bacterianas
ES557404A Expired ES8900068A1 (es) 1985-02-05 1987-02-16 Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES551659A Expired ES8800757A1 (es) 1985-02-05 1986-02-05 Procedimiento para preparar un reactivo para valorar por hemaglutinacion anticuerpos dirigidos contra toxinas bacterianas

Country Status (11)

Country Link
US (1) US5318913A (es)
EP (1) EP0193439B1 (es)
JP (1) JPS61228356A (es)
AT (1) ATE68601T1 (es)
CA (1) CA1275043A (es)
DE (1) DE3681940D1 (es)
DK (1) DK56386A (es)
ES (2) ES8800757A1 (es)
FR (1) FR2577048B1 (es)
GR (1) GR860329B (es)
PT (1) PT81970B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265201B1 (en) * 1997-01-17 2001-07-24 Regents Of The University Of Minnesota DNA molecules and protein displaying improved triazine compound degrading ability
ES2228467T3 (es) * 1999-02-03 2005-04-16 Biosante Pharmaceuticals, Inc. Particulas terapeuticas de fosfato calcico y metodos de fabricacion y su uso.
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
US20020068090A1 (en) * 1999-02-03 2002-06-06 Bell Steve J. D. Calcium phosphate particles as mucosal adjuvants
AU2001231155A1 (en) 2000-01-25 2001-08-07 Hugh Mctavish Microbes and methods for remediation
JP2002063917A (ja) * 2000-08-18 2002-02-28 Sony Corp 電気化学デバイス及びその使用方法
FR2821431B1 (fr) * 2001-02-28 2003-11-21 Louis Lery Reactif destine au depistage ante-morten d'atnc
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
WO2006050368A2 (en) 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles iin use for aesthetic or cosmetic medicine, and methods of manufacture and use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2310964A1 (de) * 1973-03-02 1974-09-05 Schering Ag Antigen- bzw. antigen-proteinkonjugatbeschichtete erythrocytenpraeparation
FR2334107A1 (fr) * 1975-12-05 1977-07-01 Pasteur Institut Procede de couplage de substances biologiques par des liaisons covalentes
FR2403559A1 (fr) * 1977-09-19 1979-04-13 Merieux Inst Nouveau reactif biologique, sa preparation et son application
DE2836046A1 (de) * 1978-08-17 1980-02-28 Behringwerke Ag Immunologisches bestimmungsverfahren
FR2478470A1 (fr) * 1980-03-24 1981-09-25 Pasteur Institut Preparations cellulaires applicables en therapeutique humaine, procede d'obtention et applications
JPS578090A (en) * 1980-06-12 1982-01-16 Shinsei Industries Co Stapler
US4403037A (en) * 1980-10-10 1983-09-06 American Hoechst Corporation Erythrocyte preparations and use thereof in hemagglutination tests
DE3206729A1 (de) * 1982-02-25 1983-09-01 Behringwerke Ag, 3550 Marburg Immunologisches agglutinationsverfahren
JPS5931453A (ja) * 1982-07-14 1984-02-20 Fujirebio Inc 梅毒抗体の測定方法

Also Published As

Publication number Publication date
ATE68601T1 (de) 1991-11-15
EP0193439A1 (fr) 1986-09-03
DK56386A (da) 1986-08-06
FR2577048B1 (fr) 1988-05-06
ES551659A0 (es) 1987-11-16
EP0193439B1 (fr) 1991-10-16
GR860329B (en) 1986-06-05
PT81970A (fr) 1986-03-01
ES8800757A1 (es) 1987-11-16
FR2577048A1 (fr) 1986-08-08
JPS61228356A (ja) 1986-10-11
PT81970B (pt) 1988-01-22
US5318913A (en) 1994-06-07
ES8900068A1 (es) 1988-11-16
DE3681940D1 (de) 1991-11-21
DK56386D0 (da) 1986-02-05
CA1275043A (en) 1990-10-09

Similar Documents

Publication Publication Date Title
SE8602404D0 (sv) Ny formulering
AU1285592A (en) Methods for increasing extracellular adenosine and for stabilizing mast cells
ES8605375A1 (es) Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias.
AU1141288A (en) Production of proteins in active forms
ES557404A0 (es) Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas.
FI891283A (fi) Ifosfamid-mesna-lyofilisat och foerfarande foer dess framstaellning.
SE8300320L (sv) Anvendning av en saltlosning av monoklonala antikroppar med relativt hog salthalt vid blodgruppsbestemning
SE7903821L (sv) Kinetisk metning av glykoskoncentrationen i kroppsvetskor och beredning herfor
SE7904161L (sv) Komposition for minskning av fenylalaninnivan i blod och anvendning derav
AU589970B2 (en) Animal litter and process for the production thereof
EP0300381A3 (en) Immunological detection of herbicides
LU90378I2 (fr) Tetravac
FR2563630B1 (fr) Anticorps monoclonaux anticytomegalovirus et procedes pour le diagnostic in vitro des infections par les cytomegalovirus humains et d'une proteine-kinase inductible par les cytomegalovirus et susceptible d'etre reconnue par les susdits anticorps monoclonaux
FI885017A (fi) Mikro-organismien kontrollointi vesijärjestelmissä 1-hydroksimetyylipyratsolien avulla
GR79499B (es)
ES8706665A1 (es) Procedimiento de preparar nuevas sales de acidos carboxilicos, terapeuticamente utiles
ES8206973A1 (es) Procedimiento de preparar soluciones desagregadas de poli- peptidos
ES503537A0 (es) Procedimiento para la determinacion de hemoglobina.
SU1387399A1 (ru) Питательная среда для культивирования лептоспир
ES8306259A1 (es) "procedimiento para la preparacion de toxoplasmas coloreados".
SU1445159A1 (ru) Способ поверхностного модифицирования резины
IT1178489B (it) Vettore clonante, procedimento per la sua costruzione e procedimento di concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante
ATE31623T1 (de) Injizierbare zusammensetzungen von bbm-928a.
GT198500045A (es) Una composicion para la higiene oral

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506